Celanese
CE · NYSE · Materials · United States
Financials at a glance
Source: SEC XBRLAnnual
Quarterly · last 8
Revenue (FY2025)
$9.5B
Net margin
-12.2%
ROE
-28.8%
Revenue CAGR (2y)
-6.5%
EPS (FY2025)
-10.64
Net profit (FY2025)
$-1.2B
Ask MarketChacha about CE
Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.
Why it moved
- Sep 2, 2026
Celanese shares rose amid ongoing investor focus on the large gap between the current price (~$44) and consensus analyst targets (~$63-64), following the recent Q2 earnings beat and Nutrinova stake sale to Mitsui for $152M announced Aug 31.
- Aug 4, 2026
No specific company catalyst or filing identified for the move; Celanese shares rose with the broader market or sector ahead of its Q2 earnings report.
· confidence: low - Jul 27, 2026
No specific company catalyst identified for the decline; Celanese moved lower with the broader market or sector ahead of its Q2 earnings release scheduled for early August.
· confidence: low - Jul 22, 2026
Celanese shares rose after Deutsche Bank reiterated its Buy rating in a Catalyst Call ahead of Q2 earnings.
Daily moves with the verified reason behind them. Education only — not investment advice.
Financials
Yearly
| Period | Revenue | Net profit | EPS | Net margin | ROE |
|---|---|---|---|---|---|
| FY2025 | $9.5B | $-1.2B | -10.64 | -12.2% | -28.8% |
| FY2024 | $10.3B | $-1.5B | -14.11 | -15.0% | -30.1% |
| FY2023 | $10.9B | $1.9B | 17.76 | 17.8% | 27.5% |
Quarterly
| Period | Revenue | Net profit | EPS | Net margin |
|---|---|---|---|---|
| 2026Q2 | $2.8B | $125.0M | 1.13 | 4.5% |
| 2026Q1 | $2.3B | $44.0M | 0.40 | 1.9% |
| 2025Q3 | $2.4B | $-1.4B | -12.39 | -56.1% |
| 2025Q2 | $2.5B | $197.0M | 1.80 | 7.8% |
| 2025Q1 | $2.4B | $-24.0M | -0.22 | -1.0% |
| 2024Q3 | $2.6B | $113.0M | 1.03 | 4.3% |
| 2024Q2 | $2.7B | $155.0M | 1.41 | 5.8% |
| 2024Q1 | $2.6B | $121.0M | 1.10 | 4.6% |
| 2023Q3 | $2.7B | $951.0M | 8.69 | 34.9% |
| 2023Q2 | $2.8B | $220.0M | 2.01 | 7.9% |
| 2023Q1 | $2.9B | $91.0M | 0.83 | 3.2% |
Figures as reported, in reporting currency. Source: SEC XBRL.
Filings & announcements
2026
- SEC8/5/2026
- SEC8/4/2026material
- SEC8/4/2026material
- SEC8/4/2026material
- SEC6/10/2026material
- SEC5/6/2026
- SEC5/5/2026material
- SEC5/5/2026material
- SEC4/20/2026material
- SEC4/17/2026material
- SEC3/4/2026material
- SEC2/24/2026
- SEC2/17/2026material
- SEC2/17/2026material
- SEC1/6/2026material
2025
- SEC12/17/2025material
- SEC12/16/2025material
- SEC12/4/2025material
- SEC12/2/2025material
- SEC11/7/2025
- SEC11/6/2025material
- SEC11/6/2025material
- SEC10/28/2025material
- SEC10/28/2025material
- SEC8/11/2025material
In the news
- Is Celanese (CE) Undervalued Following Its Q2 Earnings Beat And Guidance Reaffirmation?simplywall.st · 9/4/2026
- Celanese Corp. stock edges lower as investors digest Q2 2026 earnings beatad-hoc-news.de · 9/4/2026
- Celanese Corp. stock gains as Nutrinova stake sale reshapes portfolioAD HOC NEWS · 9/3/2026
- Celanese Corp (CE) Shares Surge 5.7% -- What GF Score of 67 Tells InvestorsGuruFocus · 9/2/2026
- Celanese Corp. stock reacts to Nutrinova stake sale and JV reshapingad-hoc-news.de · 9/2/2026
- Sudarshan Chemical divests its stake in VP4 Frankfurt to Celanese Corporation, USABusiness Standard · 9/1/2026
- Celanese stock steady as Nutrinova stake sale and valuation gap shape the outlookAD HOC NEWS · 9/1/2026
- Celanese stock holds below recent highs as institutional buying supports the sharesad-hoc-news.de · 8/31/2026
Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.